When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?-Reference-Cited by-同舟云学术

When is LABA/LAMA Better than LAMA in GOLD Group B or D Patients for Reducing Acute Exacerbations of COPD?

Published:2023 Issue:3 Volume:59 Page:180
ISSN:2233-7385
Container-title:Chonnam Medical Journal
language:en
Short-container-title:Chonnam Med J

Author:

Shin Hong-Joon¹,Kim Yu-Il¹,Kim Youlim²,Lee Chang Youl³,Ra Seung Won⁴,Moon Ji-Yong⁵,Jung Ki-Suck⁶,Yoo Kwang Ha²,Shin Kyeong-Cheol⁷,Lim Sung-Chul¹,

Affiliation:

1. Division of Pulmonary Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea.

2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.

3. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea.

4. Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

5. Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

6. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.

7. Division of Pulmonology and Allergy, Regional Center for Respiratory Disease, Yeungnam University Medical Center, Daegu, Korea.

Publisher

XMLink

Subject

Immunology

Link

https://cmj.ac.kr/pdf/10.4068/cmj.2023.59.3.180

Reference22 articles.

1. Comorbidities in Chronic Obstructive Pulmonary Disease

2. Chronic obstructive pulmonary disease: current burden and future projections

3. Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study

4. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40

5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2023 report [Internet]. Fontana. GOLD. 2023. cited 2023 Mar 15. Available from: https://goldcopd.org/2023-gold-report-2/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy;Frontiers in Medicine;2024-08-06